Quantcast
Last updated on April 18, 2014 at 8:37 EDT

Latest Post-SSRI sexual dysfunction Stories

2005-11-16 13:08:15

By Will Boggs, MD NEW YORK (Reuters Health) - Contrary to the findings in rodent studies, a class of drugs commonly used to treat depression, selective serotonin reuptake inhibitors (SSRIs) that include drugs such as Prozac, do not appear to increase the risk of breast cancer, according to a report in the American Journal of Epidemiology. "Physicians can feel confident that the evidence has accumulated that use of SSRIs for four to five years does not increase the risk of breast...